Physician profile
Abigail Pearson
NPI 1659886059
$9,223.44
in general payments reported to CMS, 2019-2025
47 companies · $946 in 2025
The $946 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,927 · 2022: $2,037 · 2023: $2,045 · 2024: $1,268 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,165 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,165.07 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $859.10 | 2021-2025 | |
| Novo Nordisk INC | $845.05 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $804.99 | 2021-2024 | |
| Glaxosmithkline, LLC. | $706.15 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $665.49 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Astrazeneca Pharmaceuticals LP | $600.11 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $562.54 | 2021-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $516.54 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $447.49 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $412.03 | 2021-2025 | |
| Amgen INC. | $335.30 | 2021-2025 | Evenity, Prolia, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $278.75 | 2021-2023 | Trintellix |
| Merck Sharp & Dohme LLC | $255.59 | 2021-2023 | Belsomra, Steglatro, Steglujan |
| Corium, LLC | $245.14 | 2022-2023 | Azstarys |
| Amarin Pharma, INC. | $201.34 | 2021-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.